These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11520482)

  • 1. Making practical sense of clinical trial data in decreasing cardiovascular risk.
    Castelli WP
    Am J Cardiol; 2001 Aug; 88(4A):16F-20F. PubMed ID: 11520482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]].
    Tomiyama H; Doba N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101
    [No Abstract]   [Full Text] [Related]  

  • 3. Selections from current literature: the fight over fat: is pharmacological lipid lowering useful for coronary primary prevention?
    Green L
    Fam Pract; 1997 Oct; 14(5):411-5. PubMed ID: 9472378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for aggressive lipid regulation.
    Gotto AM
    Hosp Pract (1995); 1997 Feb; 32(2):145-9, 155-6. PubMed ID: 9040426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
    Berger M
    Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypercholesterolemia in women: equality, effectiveness, and extrapolation of evidence.
    Pearson TA; Myerson M
    JAMA; 1997 Apr 23-30; 277(16):1320-1. PubMed ID: 9109473
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol lowering and mortality: the importance of considering initial level of risk.
    Smith GD; Song F; Sheldon TA
    BMJ; 1993 May; 306(6889):1367-73. PubMed ID: 8518602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we aggressive enough in lowering cholesterol?
    Waters DD
    Am J Cardiol; 2001 Aug; 88(4A):10F-5F. PubMed ID: 11520481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of statins in acute coronary syndromes.
    Foody JM; Nissen SE
    Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
    Deller M; Huth K
    Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipid-lowering therapy in multiple risk factor management.
    Esper RJ
    Drugs; 1998; 56 Suppl 1():1-7; discussion 33. PubMed ID: 9740535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?
    Jones PH
    Drugs; 2000 May; 59(5):1127-35. PubMed ID: 10852644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lowering LDL cholesterol. How much is enough?].
    März W; Grammer TB
    Internist (Berl); 2007 Mar; 48(3):319-26. PubMed ID: 17333056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future of lipid-lowering trials: what else do we need to know?
    Jones PH
    Am J Cardiol; 1998 Sep; 82(6A):32M-38M. PubMed ID: 9766346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.